Dietary supplementation with Pediococcus pentosaceus enhances the innate immune response in and promotes growth of Litopenaeus vannamei shrimp.
- 2022-06-08
- Journal of Fish Diseases 45(9)
- Bao Le
- Dong-geun Kim
- N. N. Phước
- Nguyen Thi Hoang Linh
- S. Yang
- PubMed: 35675520
- DOI: 10.1111/jfd.13666
Abstract
To reach the sustainable development goals on health management in Litopenaeus vannamei shrimp culture, Pediococcus pentosaceus AB01 was supplemented in shrimp diet. In this study, the control diet and three experimental diets containing P. pentosaceus AB01 (108 , 109 , 1010 CFU/g) were separately introduced to L. vannamei for a 28 days feeding trial. After the feeding trial, percent weight gain, feeding efficiency, and feed conversion ratio (FCR) were significantly elevated in L. vannamei administered with P. pentosaceus AB01 at 109 and 1010 colony-forming unit (CFU)/g. Protease, amylase, and trypsin were found at higher levels in the probiotic-supplied groups. The feeding of shrimps with P. pentosaceus AB01 significantly increased innate immune response and levels of related biochemical parameters in the haemolymph. After the white spot syndrome virus (WSSV) challenge, supplementation of P. pentosaceus AB01 had significant positive effects (p < .05) on survival rate, compared to that of the control diet. The higher resistance of L. vannamei to WSSV might have been due to alterations in the gut microbiome composition and upregulation of the Toll-Like Receptor (TLR) signalling pathway. Hence, P. pentosaceus AB01 may be a promising alternative feed to promote growth rate, modulate microbiota composition, and enhance immunity in L. vannamei shrimp.
Keywords: Litopenaeus vannamei; Pediococcus pentosaceus; innate immune response; microbiota; white spot syndrome virus.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Pediococcus pentosaceus KABP™-041 | Enhanced Innate Immune Function | Beneficial | Large |
Pediococcus pentosaceus KABP™-041 | Enhanced Toll-Like Receptor (TLR) Signalling Pathway | Beneficial | Moderate |
Pediococcus pentosaceus KABP™-041 | Improved Survival Rate Following WSSV Challenge | Beneficial | Large |
Pediococcus pentosaceus KABP™-041 | Increased Body Weight | Beneficial | Large |
Pediococcus pentosaceus KABP™-041 | Increased Protease Levels | Beneficial | Large |
Pediococcus pentosaceus MAK99P15P | Altered Gut Microbiota Composition | Beneficial | Moderate |
Pediococcus pentosaceus MAK99P15P | Improved Cell Survival Rates | Beneficial | Large |
Pediococcus pentosaceus MAK99P15P | Improved Enzyme Activity | Beneficial | Large |
Pediococcus pentosaceus MAK99P15P | Improved Immune Response | Beneficial | Large |
Pediococcus pentosaceus MAK99P15P | Increased Body Weight | Beneficial | Large |
Pediococcus pentosaceus PP06 | Altered Gut Microbiota Composition | Beneficial | Moderate |
Pediococcus pentosaceus PP06 | Enhanced Innate Immune Function | Beneficial | Large |
Pediococcus pentosaceus PP06 | Improved Enzyme Activity | Beneficial | Large |
Pediococcus pentosaceus PP06 | Improved Weight Gain | Beneficial | Large |
Pediococcus pentosaceus PP06 | Increased Survival Rate against White Spot Syndrome Virus | Beneficial | Large |